Gene-edited stem cells treat HIV with mixed success, researchers find

For the first time, researchers have used CRISPR gene-editing technology to try to treat a person infected with Human Immuno-deficiency Virus (HIV). Scientists in China engineered human stem cells to mimic a rare form of natural immunity to the virus and transplanted them into a man with HIV and blood cancer.